Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect

Loading...
Thumbnail Image
Authors
Medical Center Staff
Issue Date
2009-01-09
Type
Language
en_US
Keywords
Research Projects
Organizational Units
Journal Issue
Alternative Title
Abstract
Description
Citation
Publisher
Stony Brook Medicine, Stony Brook University
License
Stony Brook University
Journal
Volume
Issue
PubMed ID
DOI
ISSN
EISSN